[NKTR] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
05-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 25.03%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 90,122 92,055 101,907 152,915 114,617 1,193,323 307,711 -18.50%
PBT -276,256 -364,983 -523,280 -443,947 -440,054 682,725 -96,076 19.23%
Tax -200 3,215 557 493 613 1,412 616 -
NP -276,056 -368,198 -523,837 -444,440 -440,667 681,313 -96,692 19.09%
Tax Rate - - - - - -0.21% - -
Total Cost 366,178 460,253 625,744 597,355 555,284 512,010 404,403 -1.64%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -306.31 -399.98 -514.03 -290.65 -384.47 57.09 -31.42 46.13%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.45 -1.97 -2.86 -2.49 -2.52 3.78 -0.62 15.20%
EPS Diluted -1.45 -1.97 -2.86 -2.49 -2.52 3.78 -0.62 15.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.